Arkolith/Insider Trading/ADPT/Form 4

Robins Chad M

CEO and Chairman, DirectorAdaptive Biotechnologies Corp (ADPT) · full profile →Form 4 · filed Apr 8, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.8M
Net Open-Market Flow
-$1.8M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 8, 2026Sell(S)37K$15.19$566K2.2M
Apr 6, 2026Sell(S)83K$14.41$1.2M2.2M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001780649-26-000011) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML